According to ADC Therapeutics's latest financial reports and stock price the company's current Operating Margin is -160.11%. At the end of 2023 the company had an Operating Margin of -280.94%.
Year | Operating Margin | Change |
---|---|---|
2023 | -280.94% | 301.67% |
2022 | -69.94% | -90.57% |
2021 | -741.53% | |
2019 | -4,953.08% | -54.05% |
2018 | -10,778.25% | 116.37% |
2017 | -4,981.36% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.